CV Sciences, Inc. Announces Annual Meeting of Stockholders on June 3, 2024

TL;DR

<b>CV Sciences, Inc. will hold its virtual annual meeting on June 3, 2024, to elect directors, ratify auditors, and vote on executive compensation.</b>

AI Summary

CV Sciences, Inc. (CVSI) filed a Proxy Statement (DEF 14A) with the SEC on April 12, 2024. CV Sciences, Inc. will hold its annual meeting of stockholders on June 3, 2024, at 10:00 a.m. Pacific Time. The meeting will be conducted in a completely virtual format. Stockholders can attend and submit questions via the internet at https://tinyurl.com/viavid-webcast?ei=1664232. The agenda includes electing three directors, ratifying Haskell & White LLP as independent auditors for FY2024, and approving executive compensation on an advisory basis. Voting can be done by proxy using methods provided on the Notice and/or Proxy Card.

Why It Matters

For investors and stakeholders tracking CV Sciences, Inc., this filing contains several important signals. The virtual format aims to provide a consistent and convenient experience for all stockholders, regardless of their location. Key proposals include the election of directors and the ratification of the independent auditor, which are standard governance procedures for public companies.

Risk Assessment

Risk Level: — CV Sciences, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational disclosures that would significantly alter the risk profile.

Analyst Insight

Stockholders should review the proposals, particularly director elections and executive compensation, and cast their votes by proxy before the meeting.

Key Numbers

• 3 — Directors to be elected (Purpose of the annual meeting)
• 2024 — Fiscal Year (For which Haskell & White LLP is being ratified as auditor)

Key Players & Entities

• CV Sciences, Inc. (company) — Registrant and Company Name
• June 3, 2024 (date) — Date of Annual Meeting
• Haskell & White LLP (company) — Independent registered public accounting firm
• December 31, 2024 (date) — Fiscal year end for auditor ratification

FAQ

Risk Factors

• Compliance with SEC Regulations [low — regulatory]: The company must comply with all SEC rules and regulations regarding proxy solicitations and annual meetings.
• Virtual Meeting Format [low — operational]: Ensuring a smooth and accessible virtual meeting experience for all stockholders is crucial for effective communication and participation.

Industry Context

CV Sciences, Inc. operates in the pharmaceutical preparations industry, with this filing being a standard corporate governance document.

Regulatory Implications

The filing adheres to the requirements of Section 14(a) of the Securities Exchange Act of 1934, governing the solicitation of proxies.

What Investors Should Do

1. Review the proxy statement for details on director nominees and their qualifications.
2. Understand the advisory vote on named executive officer compensation.
3. Ensure voting instructions for the annual meeting are followed, either by proxy or during the virtual meeting.

Key Dates

• 2024-06-03: Annual Meeting of Stockholders — Election of directors, ratification of auditors, and advisory vote on executive compensation.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a routine proxy statement for an annual meeting, and does not represent a change from previous filings of this nature.

Key Financial Figures

• $0.0001 — ompany&#x2019;s common stock, par value $0.0001 per share ( Common Stock ), were issued

Filing Documents

• cvsi_proxy_def_14a_2024.htm (DEF 14A) — 475KB
• img36015394_0.jpg (GRAPHIC) — 84KB
• img36015394_1.jpg (GRAPHIC) — 127KB
• 0000950170-24-043834.txt (&nbsp;) — 756KB

From the Filing

DEF 14A 1 cvsi_proxy_def_14a_2024.htm DEF 14A DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 CV SCIENCES, INC. (Name of Registrant as Specified In Its Charter) N/A (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. CV SCIENCES, INC. 9530 Padgett Street, Suite 107 San Diego, California 92126 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held on June 3, 2024 NOTICE IS HEREBY GIVEN that the annual meeting of the stockholders (the &#x201c; Meeting &#x201d;) of CV Sciences, Inc. (the &#x201c; Company &#x201d;, &#x201c; we &#x201d; or &#x201c; us &#x201d;) will be held on June 3, 2024, at 10:00 a.m. Pacific Time (subject to postponement(s) or adjournment(s) thereof). We have adopted a completely virtual format for our Meeting to provide a healthy, consistent and convenient experience to all stockholders regardless of location. You may attend and submit questions during the Meeting via the Internet at https://tinyurl.com/viavid-webcast?ei=1664232 . You may also attend the Meeting by proxy, and may submit questions ahead of the Meeting through the designated website. Although stockholders will not be able to vote through the virtual meeting platform during the Meeting, they will have the ability to cast their votes, using the methods set forth on the Notice and/or Proxy Card received in the mail, until the announcement is made at the Meeting that the polls are closed. For further information about the virtual Meeting, please see the Questions and Answers about the Meeting beginning on page 2 of our Proxy Statement. The Meeting will have the following purposes: (1) To elect three directors to hold office until the next annual meeting of stockholders or until their successors are duly elected and qualified, subject to prior death, resignation or removal; (2) To ratify the selection of Haskell & White LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; (3) To approve, on a non-binding advisory basis, named executive officer compensation; and (4) To consider and act upon such other business as may properly be brought before the Meeting or any adjournments or postponement thereof by or at the direction of our Board of Directors. The matters are more fully discussed in the attached Proxy Statement. Action may be taken on any one of the foregoing proposals at the Meeting on the date specified above or on any date or dates to which the Meeting may be postponed or adjourned. We do not expect to transact any other business at the Meeting. We have elected to provide access to our proxy materials primarily electronically via the Internet, pursuant to the &#x201c;Notice and Access&#x201d; method regulations promulgated by the U.S. Securities and Exchange Commission. We believe this method conserves natural resources and significantly reduces the costs of the Meeting. On or about April 11, 2024, we are mailing a one-page Notice of Internet Availability of Proxy Materials (the &#x201c; Notice &#x201d;) to each of our stockholders entitled to notice of and to vote at the Meeting, which Notice contains instructions for accessing the attached Proxy Statement and our Annual Report on Form 10-K for our fiscal year ended December 31, 2023 (the &#x201c; Annual Report &#x201d;) via the Internet, as well as voting instructions. The Notice also includes instructions on how you can receive a paper copy of your proxy materials. The Proxy Statement and the Annual Report are both available on the Internet at: https://www.iproxydirect.com/CVSI. The close of business on April 5, 2024 has been fixed as the record date for determining stockholders entitled to notice of, and to vote at, the Meeting or any adjournments or postponement thereof. For at least 10 days prior to the Meeting, a complete list of stockholders entitled to vote at the Meeting will be open to any stockholder&#x2019;s examination during ordinary business hours at our principal executive offices located at 9530 Padgett Street, Suite 107, San Diego, California 92126, (855) 758-7223. Our Board of Directors has carefully reviewed and considered the foregoing proposals and has concluded that each proposal is in the best interests of the Company and its stockholders. Therefore, our Board of Dire

View Full Filing

View this DEF 14A filing on SEC EDGAR